Search Results - "Tsugaru, Kai"

Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors by Shimozaki, Keitaro, Hayashi, Hideyuki, Tanishima, Shigeki, Horie, Sara, Chida, Akihiko, Tsugaru, Kai, Togasaki, Kazuhiro, Kawasaki, Kenta, Aimono, Eriko, Hirata, Kenro, Nishihara, Hiroshi, Kanai, Takanori, Hamamoto, Yasuo

“…Various malignancies exhibit high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR). The MSI-IVD kit, a polymerase chain reaction…”
Get full text

Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis by Hayashi, Yukie, Hosoe, Naoki, Takabayashi, Kaoru, Limpias Kamiya, Kenji J. L., Tsugaru, Kai, Shimozaki, Keitaro, Hirata, Kenro, Fukuhara, Kayoko, Fukuhara, Seiichiro, Mutaguchi, Makoto, Sujino, Tomohisa, Sukawa, Yasutaka, Hamamoto, Yasuo, Naganuma, Makoto, Takaishi, Hiromasa, Shimoda, Masayuki, Ogata, Haruhiko, Kanai, Takanori

Get full text

Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study) by Shoji, Hirokazu, Kudo-Saito, Chie, Nagashima, Kengo, Imazeki, Hiroshi, Tsugaru, Kai, Takahashi, Naoki, Kawakami, Takeshi, Amanuma, Yusuke, Wakatsuki, Takeru, Okano, Naohiro, Narita, Yukiya, Yamamoto, Yoshiyuki, Kizawa, Rika, Muro, Kei, Aoki, Kazunori, Boku, Narikazu

“…Background Gastric cancer (GC) is one of the most common and deadly malignant diseases worldwide. Despite revolutionary advances, the therapeutic efficacy of…”
Get full text

546 The FSTL1-DIP2A axis as a promising target in the anti-PD1 therapy of advanced gastric cancer by Kudo-Saito, Chie, Boku, Narikazu, Shoji, Hirokazu, Imazeki, Hiroshi, Nagashima, Kengo, Tsugaru, Kai, Takahashi, Naoki, Kawakami, Takeshi, Amanuma, Yusuke, Wakatsuki, Takeru, Okano, Naohiro, Narita, Yukiya, Yamamoto, Yoshiyuki, Kizawa, Rika, Aoki, Kazunori, Muro, Kei

“…BackgroundWe previously demonstrated that FSTL1 is a key driver of cancer stemness and metastasis accompanied by immune exhaustion and dysfunction leading to…”
Get full text

The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study by Shimozaki, Keitaro, Hirata, Kenro, Horie, Sara, Chida, Akihiko, Tsugaru, Kai, Hayashi, Yukie, Kawasaki, Kenta, Miyanaga, Ryoichi, Hayashi, Hideyuki, Mizuno, Ryuichi, Funakoshi, Takeru, Hosoe, Naoki, Hamamoto, Yasuo, Kanai, Takanori

“…Despite the proven efficacy of immune checkpoint inhibitors (ICIs) against various types of malignancies, they have been found to induce immune-related adverse…”
Get full text

P57-2 Retrospective study of second-line FOLFOX versus S1 for advanced biliary tract cancer by Chida, Akihiko, Hamamoto, Yasuo, So, Eiichiro, Shimizu, Satoko, Kishimoto, Shotaro, Horie, Sara, Saito, Yuki, Shimozaki, Keitaro, Togasaki, Kazuhiro, Tsugaru, Kai, Hirata, Kenro, Hayashi, Hideyuki, Kanai, Takanori

Get full text

MO70-5 The clinical outcomes for anamorelin in advanced gastrointestinal cancer patients with cancer cachexia by Nishimura, Ari, Hamauchi, Satoru, Notsu, Akifumi, Kawaguchi, Daiki, Tsugaru, Kai, Fushiki, Kunihiro, Oshima, Kotoe, Tsushima, Takahiro, Kawakami, Takeshi, Todaka, Akiko, Yokota, Tomoya, Yasui, Hirofumi, Onozawa, Yusuke, Yamazaki, Kentaro

Get full text

P22-2 A single center treatment experience of combination with chemotherapy and nivolumab for HER2-negative gastric cancer by Tsugaru, Kai, Kawakami, Takeshi, Kawaguchi, Daiki, Nishimura, Ari, Fushiki, Kunihiro, Oshima, Kotoe, Tsushima, Takahiro, Todaka, Akiko, Hamauchi, Satoshi, Yokota, Tomoya, Onozawa, Yusuke, Yasui, Hirofumi, Yamazaki, Kentaro

Get full text

Clinical significance of D-amino acid profile for cancer detection in early stage and prediction of efficacy of nivolumab in gastric cancer by Tsugaru, Kai, Sujino, Tomohisa, Mita, Masashi, Sasabe, Jumpei, Chida, Akihiko, Harada, Yosuke, Hirata, Kenro, Sukawa, Yasutaka, Kato, Motohiko, Kawakubo, Hirofumi, Hamamoto, Yasuo, Kanai, Takanori

“…453 Background: Some metabolites from gut microbiota are reported to associate with immunotherapy response. D-amino acids (D-AAs), enantiomer of L-amino acids…”
Get full text

IL33-ST2 axis as a diagnostic and therapeutic biomarker in nivolumab therapy for advanced gastric cancer by Kudo-Saito, Chie, Boku, Narikazu, Shoji, Hirokazu, Imazeki, Hiroshi, Nagashima, Kengo, Tsugaru, Kai, Takahashi, Naoki, Kawakami, Takeshi, Amanuma, Yusuke, Wakatsuki, Takeru, Okano, Naohiro, Narita, Yukiya, Yamamoto, Yoshiyuki, Kizawa, Rika, Aoki, Kazunori, Muro, Kei

“…4021 Background: We previously identified IL33 as a determinant of treatment resistance of cancer using mouse tumor models and clinical samples. We showed that…”
Get full text

Analysis of risk factors for immune-related adverse events in various solid tumors using real-world data by Shimozaki, Keitaro, Sukawa, Yasutaka, Sato, Yasunori, Horie, Sara, Chida, Akihiko, Tsugaru, Kai, Togasaki, Kazuhiro, Kawasaki, Kenta, Hirata, Kenro, Hayashi, Hideyuki, Hamamoto, Yasuo, Kanai, Takanori

“…The aim of this study was to determine the risk factors for immune-related adverse events (irAEs) induced by immune checkpoint inhibitors. The authors…”
Get full text

LAG3-related factors to predict response to nivolumab monotherapy in advanced gastric cancer (WJOG10417GTR study) by Tsugaru, Kai, Boku, Narikazu, Kudo-Saito, Chie, Shoji, Hirokazu, Imazeki, Hiroshi, Takahashi, Naoki, Kawakami, Takeshi, Amanuma, Yusuke, Wakatsuki, Takeru, Okano, Naohiro, Narita, Yukiya, Yamamoto, Yoshiyuki, Kizawa, Rika, Nagashima, Kengo, Aoki, Kazunori, Muro, Kei

“…425 Background: Blocking immune checkpoint (IC) pathways, particularly mediated by PD1 and PDL1, has attracted great attention as a promising strategy for…”
Get full text

Clinical response to subsequent chemotherapy after nivolumab in patients with advanced gastric cancer by Tsugaru, Kai, Sukawa, Yasutaka, Shimozaki, Keitaro, Togasaki, Kazuhiro, Kawasaki, Kenta, Hirata, Kenro, Hayashi, Hideyuki, Hamamoto, Yasuo, Kanai, Takanori, Takaishi, Hiromasa

Get full text

P1-022Clinical response to subsequent chemotherapy after nivolumab in patients with advanced gastric cancer by Tsugaru, Kai, Sukawa, Yasutaka, Shimozaki, Keitaro, Togasaki, Kazuhiro, Kawasaki, Kenta, Hirata, Kenro, Hayashi, Hideyuki, Hamamoto, Yasuo, Kanai, Takanori, Takaishi, Hiromasa

“…Abstract Backgroud Recent studies reported that anti-PD-1 antibody increases the sensitivity of subsequent chemotherapy in several types of cancer. However,…”
Get full text

Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia by Chida, Akihiko, Kawasaki, Kenta, Kuramoto, Junko, Hayashi, Hideyuki, Kawahara, Toru, Makiuchi, Satomi, So, Eiichiro, Shimizu, Satoko, Kishimoto, Shotaro, Horie, Sara, Saito, Yuki, Shimozaki, Keitaro, Tsugaru, Kai, Togasaki, Kazuhiro, Hirata, Kenro, Nishihara, Hiroshi, Kanai, Yae, Kanai, Takanori, Hamamoto, Yasuo

“…The development of tyrosine-kinase inhibitors has improved survival rates for patients with gastrointestinal stromal tumors (GISTs). Despite the progress, not…”
Get full text

A retrospective study of immune-related adverse events in various solid tumors by Shimozaki, Keitaro, Sukawa, Yasutaka, Beppu, Noriko, Kurihara, Isao, Suzuki, Shigeaki, Asoda, Seiji, Ozawa, Hiroyuki, Mizuno, Ryuichi, Funakoshi, Takeru, Ikemura, Shinnosuke, Tsugaru, Kai, Togasaki, Kazuhiro, Kawasaki, Kenta, Hirata, Kenro, Hayashi, Hideyuki, Hamamoto, Yasuo, Kanai, Takanori, Takaishi, Hiromasa

Get full text

P2-199A retrospective study of immune-related adverse events in various solid tumors by Shimozaki, Keitaro, Sukawa, Yasutaka, Beppu, Noriko, Kurihara, Isao, Suzuki, Shigeaki, Asoda, Seiji, Ozawa, Hiroyuki, Mizuno, Ryuichi, Funakoshi, Takeru, Ikemura, Shinnosuke, Tsugaru, Kai, Togasaki, Kazuhiro, Kawasaki, Kenta, Hirata, Kenro, Hayashi, Hideyuki, Hamamoto, Yasuo, Kanai, Takanori, Takaishi, Hiromasa

“…Abstract Background Immune checkpoint inhibitors (ICIs) have been approved in various type of cancers. Although ICIs are less toxic than cytotoxic…”
Get full text

The Effectiveness and Feasibility of Palliative Care via Video Telemedicine for Patients with Advanced Cancer: A Nonrandomized Prospective Clinical Trial Comparing Combination of Telemedicine and in-Person Care with in-Person Care Alone by Chida, Akihiko, Hamamoto, Yasuo, Hirata, Kenro, Sato, Yasunori, So, Eiichiro, Kishimoto, Shotaro, Noguchi, Satoko, Horie, Sara, Saito, Yuki, Shimozaki, Keitaro, Tsugaru, Kai, Togasaki, Kazuhiro, Kawasaki, Kenta, Hayashi, Hideyuki, Kanai, Takanori

“…Background: Palliative care has been shown to be effective for patients with advanced cancer; however, the best approach to deliver palliative care needs to be…”
Get full text

Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors by Shimozaki, Keitaro, Sukawa, Yasutaka, Beppu, Noriko, Kurihara, Isao, Suzuki, Shigeaki, Mizuno, Ryuichi, Funakoshi, Takeru, Ikemura, Shinnosuke, Tsugaru, Kai, Togasaki, Kazuhiro, Kawasaki, Kenta, Hirata, Kenro, Hayashi, Hideyuki, Hamamoto, Yasuo, Takaishi, Hiromasa, Kanai, Takanori

“…Immune checkpoint inhibitors (ICIs) have been approved for various types of cancer; however, they cause a broad spectrum of immune-related adverse events…”
Get full text